VSee Health (VSEE) Stock Price, News & Analysis

Company Overview

VSee Health, Inc. is a healthcare technology company that provides virtual care solutions for healthcare organizations, clinicians and patients. Its platform is designed to support telehealth visits, virtual specialty care, remote patient monitoring and coordination of clinical services.

The company combines telemedicine software with clinical workflows and care-delivery services. Its solutions can support secure video consultations, patient engagement, care-team communication and the delivery of specialized medical services across distributed healthcare settings.

VSee Health serves healthcare providers and other organizations seeking to expand access to care through digital and remote-care programs. The company’s offerings are intended to help connect patients with clinicians across geographic boundaries while integrating virtual care into broader healthcare operations.

Key Stats

• Today's Range: $1.50 to $2.20
• 50-Day Range: $0.97 to $7.12
• 52-Week Range: $0.01 to $2.52
• Volume: 8,936 shs
• Average Volume: 3.64 million shs
• Market Capitalization: $7.57 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

VSee Health Stock Analysis - MarketRank™

VSee Health scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

VSee Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

VSee Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of VSee Health is -3.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of VSee Health is -3.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for VSEE.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

VSee Health does not currently pay a dividend.

Dividend Growth

VSee Health does not have a long track record of dividend growth.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: N/A

News Sentiment

VSee Health has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for VSee Health this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, VSee Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.87% of the stock of VSee Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

1.01% of the stock of VSee Health is held by institutions.

Company Calendar

• Last Earnings: 3/31/2026
• Today: 10/02/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:VSEE
• Previous Symbol: NASDAQ:DHAC
• CIK: 1864531
• Web: vsee.com
• Phone: (561) 672-7068
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.37)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.71 million
• Net Margins: -92.36%
• Pretax Margin: -91.82%
• Return on Equity: -11,636.34%
• Return on Assets: -68.62%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 0.41
• Quick Ratio: 0.41

Sales & Book Value

• Annual Sales: $14.46 million
• Price / Sales: 0.52
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.01) per share
• Price / Book: -210.32

Miscellaneous

• Outstanding Shares: 3,600,000
• Free Float: N/A
• Market Cap: $7.57 million
• Optionable: N/A
• Beta: N/A